These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6554111)
1. Metabolic complications of induction therapy for leukemia and lymphoma. Cohen DG Cancer Nurs; 1983 Aug; 6(4):307-10. PubMed ID: 6554111 [No Abstract] [Full Text] [Related]
2. [Metabolic and nutritional complications of specific support measures in malignant hemopathies]. Gandarillas MA; Conde E; de las Heras G; Bello C; Richard C; Iriondo A; Garijo J; Zubizarreta A Sangre (Barc); 1985; 30(4-B):578-610. PubMed ID: 3909468 [No Abstract] [Full Text] [Related]
3. [Electrolytic changes in children with acute lymphoblastic leukemia during remission induction]. Benítez H; Arreguín L; Velásquez L; Bernaldez R; Juan L; Farfán J; Díaz S; Gaona A; Martínez MC Sangre (Barc); 1995 Jun; 40(3):213-7. PubMed ID: 7570274 [TBL] [Abstract][Full Text] [Related]
4. [Water-electrolyte balance disorders in patients with hemolymphopathies. Notes on physiopathology and therapy]. De Ritis G; Pietropaoli P Clin Ter; 1981 Dec; 99(5):531-54. PubMed ID: 7037275 [No Abstract] [Full Text] [Related]
5. Hyperuricemia in leukemia and lymphoma. I. Clinical findings and pathophysiology. Pochedly C N Y State J Med; 1973 May; 73(9):1085-92. PubMed ID: 4572306 [No Abstract] [Full Text] [Related]
6. Letter: Hyperphosphatemia and hypocalcemia in neoplastic disorders. N Engl J Med; 1974 Apr; 290(15):857-9. PubMed ID: 4361763 [No Abstract] [Full Text] [Related]
7. Alterations in electrolyte equilibrium in patients with acute leukemia. Filippatos TD; Milionis HJ; Elisaf MS Eur J Haematol; 2005 Dec; 75(6):449-60. PubMed ID: 16313256 [TBL] [Abstract][Full Text] [Related]
8. [Letter: Prevention of hyperuricemic complications caused by treatment of acute leukemia]. Sebahoun G; Carcassonne Y Nouv Presse Med; 1976 Jan; 5(3):146. PubMed ID: 1264656 [No Abstract] [Full Text] [Related]
9. [Acute tumor lysis. A problem in pediatric oncology]. Lobo-Sanahuja JF; García I; Vargas G; Madrigal G; Jiménez E; Norza M Bol Med Hosp Infant Mex; 1982 Mar; 39(3):215-20. PubMed ID: 7093027 [No Abstract] [Full Text] [Related]
10. Hyperuricemia in leukemia and lymphoma. Pochedly C Postgrad Med; 1974 Jun; 55(6):93-9. PubMed ID: 4831494 [No Abstract] [Full Text] [Related]
11. [Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)]. Vigo P; Ortolani S; Soldati L; Girardello R; Fleischmann L; Polli EE Haematologica; 1981 Oct; 66(5):656-66. PubMed ID: 6796473 [No Abstract] [Full Text] [Related]
12. [Antiblastic therapy and cytolysis in infantile leukemia]. Masera G; Carnelli V; Corbella E; Uderzo C Minerva Med; 1975 Jul; 66(52):2597-604. PubMed ID: 1153115 [No Abstract] [Full Text] [Related]
13. [Indomethacin in hemoblastosis]. Treske U Arzneimittelforschung; 1971 Nov; 21(11):1832-3. PubMed ID: 4944970 [No Abstract] [Full Text] [Related]
14. The Ommaya reservoir in chemotherapy for malignant disease in the CNS. Jacobs A; Clifford P; Kay HE Clin Oncol; 1981 Jun; 7(2):123-9. PubMed ID: 7249435 [No Abstract] [Full Text] [Related]
15. [New chemotherapeutics in hematology]. Klener P Vnitr Lek; 1971 Mar; 17(3):249-54. PubMed ID: 5574568 [No Abstract] [Full Text] [Related]
16. [Antibody therapy in hematology and oncology--2]. Kneba M; Schrader C; Köhne H Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594 [No Abstract] [Full Text] [Related]
17. Tolerance to antineoplastic agents in children and adults. Marsoni S; Ungerleider RS; Hurson SB; Simon RM; Hammershaimb LD Cancer Treat Rep; 1985 Nov; 69(11):1263-9. PubMed ID: 2418966 [No Abstract] [Full Text] [Related]
18. [Bone necrosis as a sequela of chemotherapy in hematologically malignant disorders]. Pieters R; Taets van Amerongen AH; van Brenk AI; Veerman AJ Ned Tijdschr Geneeskd; 1989 Oct; 133(43):2117-22. PubMed ID: 2682283 [No Abstract] [Full Text] [Related]
19. Use of allopurinol for control of hyperuricemia in leukemia and lymphoma. DeConti RC; Calabresi P Conn Med; 1967 Jun; 30(6):430-6. PubMed ID: 6046076 [No Abstract] [Full Text] [Related]
20. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma. Tan CT; Hancock C; Steinherz PG; Steinherz LJ; Sorell M; Chan KW; Mondora A; Miller DR Cancer Res; 1982 Apr; 42(4):1579-81. PubMed ID: 6895864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]